Evidence map›Paper›PMID 29214556›Full record

ArticleInternational journal of legal medicine2018

Influence of genetic modifiers on sudden cardiac death cases.

Tina Jenewein, Thomas Neumann, Damir Erkapic, Malte Kuniss, Marcel A Verhoff, Gerhard Thiel, Silke Kauferstein

Abstract read
PubMed Publisher
In one paragraph

Article in International journal of legal medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.2field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Review
  3. Variant interpretation in molecular autopsy: a useful dilemma.International journal of legal medicine · 2022
    Article
  4. H1153Y-International journal of molecular sciences · 2021
    Article
  5. Sudden cardiac death-update.International journal of legal medicine · 2021
    Review
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Tina JeneweinDepartment of Legal Medicine, University Hospital of Frankfurt, Goethe University, Kennedyallee 104, 60596, Frankfurt/Main, Germany.
Thomas NeumannKerckhoff Heart and Thorax Center, Benekestraße 2, 61231, Bad Nauheim, Germany.
Damir ErkapicDiakonie Klinikum GmbH, Jung-Stilling Hospital, Siegen, Germany.
Malte KunissKerckhoff Heart and Thorax Center, Benekestraße 2, 61231, Bad Nauheim, Germany.
Marcel A VerhoffDepartment of Legal Medicine, University Hospital of Frankfurt, Goethe University, Kennedyallee 104, 60596, Frankfurt/Main, Germany.
Gerhard ThielDepartment of Biology, Plant Membrane Biophysics, Technische Universität Darmstadt, Schnittspahnstrasse 3, 64287, Darmstadt, Germany.
Silke KaufersteinDepartment of Legal Medicine, University Hospital of Frankfurt, Goethe University, Kennedyallee 104, 60596, Frankfurt/Main, Germany. kauferstein@em.uni-frankfurt.de.ORCID http://orcid.org/0000-0003-0066-8679
Goethe University Frankfurt · DEKerckhoff Klinik · DEDiakonie Klinikum Jung-Stilling · DETechnische Universität Darmstadt · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sequence variants in the ion channel genes KCNH2 and SCN5A may cause the cardiac disorder long QT syndrome (LQTS). This disorder is associated with incomplete penetrance and variable expression in KCNH2- or SCN5A-mutation carriers. Common genetic variants, if associated with a mutation, may affect the severity of this cardiac disorder. This study identified rare mutations in the cardiac ion channel genes KCNH2 and SCN5A in a SCD case, as well as in a LQTS-affected family with a history of SCD. Moreover, common variants were found to occur together within the same genes. These findings support the concept that common single-nucleotide polymorphisms (SNPs) in genes encoding cardiac ion channels can directly modulate the functional effect of mutations and therefore enhance or weaken the risk of cardiac events.

Indexed as

AdolescentAdultAmino Acid SubstitutionDeath, Sudden, CardiacERG1 Potassium ChannelExonsFemaleGene FrequencyHeterozygoteHumansLong QT SyndromeMutationNAV1.5 Voltage-Gated Sodium ChannelPedigreePolymorphism, GeneticERG1 Potassium ChannelKCNH2 protein, humanNAV1.5 Voltage-Gated Sodium ChannelSCN5A protein, humanInherited cardiac diseaseMolecular autopsySudden death

Identifiers

PMID29214556
OpenAlexW2774887810

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.